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Background: The gene ORMDL3 was shown to be associated with early-onset asthma susceptibility in multiple
independent genome-wide and candidate-gene association studies. Asthmatic patients have elevated expression
levels of this gene. ORMDL3 encodes a transmembrane protein localized in the endoplasmic reticulum (ER) that
may be involved in ER stress and inflammation. It is essential to validate the genetic associations linking ORMDL3
with asthma through functional studies that confirm the biological relevance of this gene in disease. We
investigated the effects of manipulating ORMDL3 expression levels in vitro in airway cells on innate immune
inflammatory responses, ER stress and activation of the unfolded protein response (UPR).
Methods: ORMDL3 expression levels were manipulated in airway cells using an overexpression plasmid and siRNA
technologies. Successful modulation of ORMDL3 was confirmed at both the gene and protein level. The functional
impact of modulation of ORMDL3 expression levels on inflammatory responses and activation of the UPR were
quantified using complementary cellular and molecular immunology techniques.
Results: Cells with altered ORMDL3 levels responded equally well to innate immune stimuli and produced similar
levels of pro-inflammatory cytokines compared to wild-type cells. Treatment with ER stress inducers, thapsigargin
and tunicamycin, resulted in activation of the unfolded protein response (UPR). However, we observed no
difference in UPR activation in cells with ORMDL3 knockdown compared to cells with normal ORMDL3 levels.
Conclusions: Our results suggest that ORMDL3 variation in the airway epithelium is unlikely to play a significant
role in modulating innate immune responses and the UPR in the lung.
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Asthma and allergic diseases are rapidly becoming the
most common chronic diseases in the developed world.
Current asthma therapy treats symptoms of the disease,
however it is ineffective in up to 25% of patients [1].
Asthma and allergic diseases are complex disorders
caused by the interaction of various genetic and environ-
mental factors [2-4].* Correspondence: sturvey@cfri.ca
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distribution, and reproduction in any mediumGenome-wide association studies (GWAS) have been
used to identify genes that may be involved in asthma
pathogenesis [5]. Moffatt and colleagues first reported
that multiple single nucleotide polymorphisms (SNPs)
on chromosome 17q21 linked ORMDL3 (orosomucoid
1-like 3) to the risk of developing childhood asthma [6].
This association has since been reproduced in multiple
independent studies [7-14]. However, little work has
been done to elucidate the biological and functional rele-
vance of this gene in asthma. The disadvantage of these
association studies is that they cannot differentiate be-
tween true causal SNPs and non-causal variants simply
in linkage disequilibrium with disease-causing genes. Ittral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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functional studies that confirm the biological relevance
of a gene in disease.
SNP variants have also linked ORMDL3 to inflamma-
tory bowel disease (IBD) and Type I diabetes, suggesting
that ORMDL3 may be involved in dysregulation of the
immune system [15,16]. Association of ORMDL3 in both
asthma and IBD is of interest because the lung and gut
are composed of similar mucosal surface cells and these
tissues are exposed to many potentially harmful antigens
and allergens requiring tight regulation of the mucosal
immune system [17]. This unique system is responsible
for maintaining a delicate equilibrium between antigen re-
sponsiveness and tolerance and is therefore responsible for
preventing hyper-reactivity [17]. Inappropriate immune
responses to foreign components or commensal bacteria
can lead to inflammation characteristic of asthma and IBD.
Furthermore, the polymorphisms may be involved in regu-
lation of mRNA expression of 17q21 locus genes, including
ORMDL3 [6]. The expression of ORMDL3 was recently
associated with elevated levels of IL-17 secretion [18] and
ORMDL3 was expressed at higher levels in the peripheral
blood of patients with recurrent wheeze compared to con-
trols [19]. This correlation further supports the hypothesis
that ORMDL3 is involved in immunity.
The ORMDL3 gene is a member of a family of conserved
endoplasmic reticulum (ER)-localized transmembrane pro-
teins [20]. The functions of the ORMDL proteins are cur-
rently unknown, but a recent study suggested that
ORMDL3 is involved in ER-mediated Ca2+ homeostasis
and activation of the unfolded protein response (UPR) –
ORMDL3 may inhibit sarco/endoplasmic reticulum Ca2+
ATPase (SERCA) activity [21,22]. Disruptions to ER Ca2+
concentrations can cause protein misfolding, and accumu-
lation of these unfolded proteins can lead to ER stress
[23,24]. UPR signaling cascades are initiated in response to
this stress and have been shown to activate the JNK-AP-1
and NF-κB-IKK pathways [25-27]. The ER stress response
and UPR, caused by changes in ORMDL3 expression,
can initiate inflammation through induction of cytokine
production. This mechanism may explain the role of
ORMDL3 in asthma pathogenesis. Indeed, Miller et al.
have shown that in mice ORMDL3 is an allergen and
cytokine (IL-4 or IL-13) inducible ER gene expressed
predominantly in airway epithelial cells, and that it acti-
vates the ATF6 pathway of the ER localized UPR regu-
lating expression of metalloprotease, chemokine, and
oligoadenylate synthetase genes [28].
Although the symptoms of asthma are largely driven by
dysregulated T helper type 2 (TH2) responses, innate im-
mune responses are also involved in asthma pathogenesis
[29,30]. Airway epithelia are central to host defense and
immune regulation. These cells are among the first to en-
counter environmental insults and play an important rolein shaping downstream immune responses. Any dysregu-
lation of the innate immune response can result in hyper-
sensitivity to environmental factors, leading to asthma
symptoms.
Given the multiple lines of evidence suggesting that
ORMDL3 is involved in immunity, we investigated the role
of the gene in innate immune responses of airway cells.
We hypothesized that elevated ORMDL3 levels result in
heightened inflammatory responses that are associated with
the asthmatic phenotype. Increased levels of ORMDL3 pro-
tein may in turn disrupt ER homeostasis, leading to ER
overload and activation of the UPR, initiating inflamma-
tory responses. Using an in vitro model, we manipulated
ORMDL3 expression in airway cells to determine whether
a difference in basal ORMDL3 expression affected inflam-




1HAEo¯ (1HAE) cells (SV40-transformed normal human
airway epithelial cells) were cultured in DMEM-high glu-
cose medium with 10% fetal calf serum (FCS), 2 mM L-
glutamine, and 1 mM sodium pyruvate (HyClone). A549
cells (adenocarcinomic human alveolar basal epithelial cells)
were cultured in F-12K medium supplemented with 10%
fetal calf serum (FCS), 2 mM L-glutamine, and 1 mM so-
dium pyruvate (HyClone). Cells were incubated in a 37°C,
5% CO2 incubator. All cells were cultured under non-
polarizing conditions.
Cloning ORMDL3 cDNA into pEGFP-N1 vector
The ORMDL3 gene was amplified from cDNA using for-
ward primer 50-CTAAGAATTCATGAATGTGGGCAC
AGCGCAC-30 and reverse primer 50-TACTGGTACCCC
GTACTTATTGATTCCAAAAATCCGGACT-30, introdu-
cing EcoRI and KpnI restriction endonuclease sites, re-
spectively. The ORMDL3 PCR product was then inserted
into a pEGFP-N1 eukaryotic expression vector (Clontech).
ORMDL3 and eGFP are in frame and produce a fusion
protein with eGFP expressed at the C-terminus of
ORMDL3. The construct was verified by sequencing and
is denoted as pEGFP-ORMDL3. Protein is denoted as
ORMDL3-eGFP.
Cell transfection
A549 and 1HAE cell lines were transfected with pEGFP-
ORMDL3, scramble (non-specific) or ORMDL3-specific
siRNA (pre-designed by Qiagen) using AmaxaW Cell
Line NucleofectorW Kit T (Lonza). Two ORMDL3-spe-
cific siRNAs were used. Concentrations used for trans-
fection represent pooled siRNA concentration. Cells
were seeded into a 24-well plate (BD Biosciences) at a
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well for 1HAE cells.Cell stimulation and immune response quantification
Twenty-four hours post-transfection, cells were stimu-
lated with TNF-α (200 ng/ml) (eBioscience), E. coli
K12 LPS (100 μg/ml) (InvivoGen), S. typhimurium fla-
gellin (10-200 ng/ml) (InvivoGen), or IL-1β (200 ng/ml)
(eBioscience). Stimulants and their concentrations were
chosen based on published literature or past experiments
[31-34]. Cells were stimulated for 24 hours. Supernatants
were collected and analyzed for cytokine secretion. Pro-
inflammatory cytokines, IL-6 and IL-8, were detected and
quantified using Human IL-6 and IL-8 Ready-Set-Go!W
ELISA kits (eBioscience). Experiments were repeated three
times (n = 3).ER stress induction and UPR activation
Cells were stimulated with tunicamycin (200 μg/mL) (Cal-
biochem) or thapsigargin (10 μM) (Sigma) for 2 or 4 hours
to activate the UPR. For ORMDL3 knockdown cells,
stimulation was performed 24 hours post-transfection.
RNA was extracted and expression of genes XBP-1u,
XBP-1s, and CHOP were then quantified as markers of
UPR activation. For measurement of p-eIF2α levels by
Western blot, lysates from unstimulated cells with
ORMDL3 knockdown were collected 24 hours post-trans-
fection. Experiments were repeated three times (n = 3).Table 1 Quantitative PCR primer sequences



















† c.-number if in the 50UTR, c.*number if in the 30UTR.RNA isolation and reverse transcription
RNA was extracted from lysates using E.Z.N.A.W Total
RNA Kit (Omega Bio-Tek) according to the manufac-
turer’s protocol. Extracted RNA was reverse transcribed
into cDNA using the SuperScriptW VILO™ cDNA Syn-
thesis Kit (Invitrogen). Complement DNA was diluted to
200 ng/μl prior to quantification of gene expression by
qPCR. This method was followed for all samples, unless
otherwise stated (see PCR Array).
Quantification of ORMDL3 mRNA expression
Gene expression was calculated relative to GAPDH or
PPIA (encoding cyclophilin A) and was quantified by
SYBR Green chemistry (PerfeCTa™ qPCR SuperMix,
Quanta Biosciences) using a 7300 Real Time PCR Sys-
tem (Applied Biosystems). Reactions were performed in
triplicate using the following cycling conditions: 50°C for 2
mins, 95°C for 10 mins, [95°C for 15 s, 60°C for 1 min] x 40.
The relative expression of the measured gene was calcu-
lated by the Pfaffl method [35]. The primers used are
listed in Table 1.
Western blot analysis
Cells were lysed in 50 μl RIPA Buffer + 1x HALT™ prote-
ase inhibitor (Thermo Scientific). Cell debris were removed
by centrifugation: 18,000 x g for 10 min at 4°C. Proteins
were analyzed by standard Western blotting protocols
where they were transferred onto ImmobilonW-FL transfer


















TGGAATCTCTGCCCACTTCCACTT c.-140- -54 87
Figure 1 Experimental manipulation of ORMDL3 expression.
Graph (top) shows relative ORMDL3 transcript levels. Data represents
the mean ± SEM of three experimental repeats. Statistical analysis
was performed using one-way ANOVA with Bonferroni post-test.
* p < 0.05, *** p < 0.001. Western blot analysis (bottom) shows
protein expression of ORMDL3-eGFP and β-actin as a loading
control. Blot is representative of three independent experiments.
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(Clontech), anti-ACTB antibody 1:6,000 (Cell Signaling),
anti-p-eIF2α 1:500 (Cell Signaling) and IRDyeW 680 or
800 secondary antibodies 1:8000 (Li-cor). Western blots
were visualized using an Odyssey Infrared Imaging Sys-
tem (Li-cor).
PCR array
1HAE cells co-transfected with pEGFP-ORMDL3 and
ORMDL3 siRNA (low ORMDL3 expression) were com-
pared to cells co-transfected with pEGFP-ORMDL3 and
scramble siRNA (high ORMDL3 expression) at two time-
points (2 and 24 hours) after TNF-α stimulation. Extracted
RNA was reverse transcribed into first strand cDNA using
the RT2 First Strand Kit (SABiosciences, Qiagen). Protocol
as described by the manufacturer was followed.
Two RT2 Profiler PCR arrays (SABiosciences, Qiagen),
profiling expression of 84 genes each, were used: Human
Cytokines & Chemokines and Allergy & Asthma (see
Additional file 1 for complete list). Complementary DNA
template was mixed with RT2 SYBRW Green qPCR Mas-
termix (SABiosciences, Qiagen) as follows: 1350 μL SYBR
Green Master Mix, 1248 μL nuclease-free H2O, and
102 μL cDNA (~200 ng/μL). Note: these volumes were
used as recommended by the manufacturer for use with a
7300 Real Time PCR System (Applied Biosystems). Tem-
plate was then aliquoted into PCR plates containing pre-
dispensed primers. Cycler program as provided by the
manufacturer was used. Results were analyzed using the
PCR Array Data Analysis Web Portal.
Statistical analysis
Data are shown as mean ± SEM of three separate experi-
ments. Results were analyzed using one-way ANOVA with
Bonferroni post-test. Statistical analysis was performed
using GraphPad Prism5 (GraphPad Software, Inc.). Differ-
ences with p < 0.05 were considered significant.
Results
ORMDL3 modulation in airway cells
In order to determine functional impact of ORMDL3
modulation, knockdown of the gene was performed using
siRNAs. A549 and 1HAE cells were transfected with
scramble (non-specific) or ORMDL3-specific siRNA.
Modeling variation expected to occur in the human popu-
lation, we achieved 40-70% knockdown of ORMDL3 gene
expression using siRNA concentrations of 50 nM-500 nM.
We also confirmed that ORMDL3-specific siRNA did not
affect expression of genes in the same family, ORMDL1 or
ORMDL2 (Additional file 2). Sequences of primers used
for qPCR are listed in Table 1.
ORMDL3 has 84% and 80% protein sequence homology
to ORMDL1 and ORMDL2, respectively. This presented a
challenge for confirming knockdown of ORMDL3 proteinbecause commercially available antibodies detect all three
proteins. Therefore, we were unable to show ORMDL3
protein knockdown in cells transfected with siRNA
alone. To overcome this limitation, we constructed a
fusion protein, where ORMDL3 is tagged with an
eGFP protein. Co-transfection of this overexpression plas-
mid with ORMDL3-specific siRNA enabled us to knock-
down ORMDL3 and detect changes at the protein level
using an anti-GFP antibody.
Airway cells were co-transfected with both pEGFP-
ORMDL3 and siRNA (scramble or ORMDL3). Protein and
mRNA were analyzed for gene knockdown. At the tran-
script level, we observed (Figure 1) a small but significant
increase (p < 0.05) in ORMDL3 expression in the cells
transfected with pEGFP-ORMDL3 and scramble siRNA
compared to cells alone, confirming successful overexpres-
sion of the ORMDL3 gene. Transfection with pEGFP-
ORMDL3 and increasing concentrations of ORMDL3
siRNA resulted in a titration effect of increasing ORMDL3
knockdown. One advantage to constructing a fusion pro-
tein, ORMDL3-eGFP, is that eGFP is only expressed with
expression of ORMDL3. Therefore, when cells are co-
transfected with pEGFP-ORMDL3 and siRNA, knockdown
of ORMDL3 protein could subsequently be detected by
immunoblot analysis using the anti-GFP antibody. Expres-
sion of the ORMDL3-eGFP protein was confirmed by
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in each condition. Figure 1 shows knockdown of
ORMDL3-eGFP protein, confirming that ORMDL3 siRNA
affects protein expression. The double band may be
explained by either variation in mRNA splicing or post-
translational modifications to the fusion protein, such as
acetylation, methylation, myristylation, phosphorylation,
or glycosylation.
ORMDL3 knockdown does not affect IL-6 or IL-8
production following innate immune activation
1HAE cells transfected with pEGFP-ORMDL3 and
scramble or ORMDL3-specific siRNA were stimulated
24 hours post-transfection and supernatants were col-
lected 48 hours post-transfection. Stimuli used were
TNF-α, IL-1β, LPS, and flagellin. TNF-α and IL-1β were
chosen because both are early response cytokines that
perpetuate acute inflammatory processes. LPS and flagel-
lin, in contrast, are common microbial antigens recog-
nized by the innate immune system. Two classic and
biologically-relevant NF-κB-induced cytokines with im-
portant roles in innate immunity, interleukin-6 (IL-6) and
interleukin-8 (IL-8), were measured by ELISA. Despite
confirmation of ORMDL3 mRNA and protein knockdown,
we did not observe any impact on IL-6 or IL-8 production
after stimulation as shown in Figure 2A-B. Although the
cells have low baseline responsiveness to LPS and flagellin,
our results indicate that ORMDL3 knockdown does not
enhance sensitivity to these stimuli. Similar results wereA B
Figure 2 Cytokine production in cells with ORMDL3 knockdown. A) Se
stimulated with TNF-α, LPS, flagellin, or IL-1β for 24 hours. Data represent t
performed using one-way ANOVA with Bonferroni post-test.obtained in A549 cells, as well as 1HAE cells transfected
with siRNA alone (Additional file 2).ORMDL3 knockdown does not enhance UPR activation
upon stimulation
We next explored the effects of ORMDL3 expression on
activation of the UPR. Initiation of the UPR is mediated
by one or more of the ER-membrane protein sensors:
PKR-like eukaryotic initiation factor 2α kinase (PERK),
inositol requiring enzyme 1 (IRE1), and activating tran-
scription factor-6 (ATF6) [23]. Activation of any of the
three pathways initiates signaling cascades that mediate
changes to relieve ER stress. The gene XBP-1 is a sub-
strate for IRE1 ribonuclease [24]. Upon activation of the
IRE1 pathway, the IRE1 ribonuclease removes a 26-bp
intron from the unspliced variant, XBP-1u, which results
in the spliced variant, XBP-1s [36]. This spliced variant
is the active form of the gene that contributes to ER
stress responses. CHOP transcription, in contrast, can be
induced by the PERK and ATF6 pathways [24]. Phos-
phorylated eIF2α (p-eIF2α) is an early marker of PERK
pathway activation and is upstream of CHOP induction
[23]. Expression changes in these three genes that signify
UPR activation, XBP-1u, XBP-1s, and CHOP, were deter-
mined by qPCR. We also evaluated phosphorylation of
eukaryotic initiation factor 2α (eIF2α) by Western blot,
as modulation of ORMDL3 expression has been reported
to influence eIF2α phosphorylation [21].creted IL-6 and B) IL-8 levels after cell stimulation. 1HAE cells were
he mean ± SEM of three experimental repeats. Statistical analysis was
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1HAE cells with tunicamycin and thapsigargin. Both are
inducers of ER stress – tunicamycin inhibits N-linked gly-
cosylation and thapsigargin inhibits the SERCA pump
causing ER calcium stores to be depleted [37]. Quantita-
tive measurement of transcript levels showed that both
XBP-1s and CHOP increased, while XBP-1u decreased
upon stimulation with either tunicamycin or thapsigargin
(Figure 3A-B). This confirmed the utility of measuring
these genes to monitor UPR activation.A
C
E
Figure 3 Unfolded protein response activation in cells with ORMDL3 k
A) tunicamycin or B) thapsigargin for 2 or 4 hours. Relative expression leve
unstimulated cells. 1HAE cells with ORMDL3 knockdown were stimulated w
expression levels were quantified and compared to cells transfected with s
three experimental repeats. Statistical analysis was performed using one-wa
* p < 0.05. E) Western blot analysis of p-eIF2α with β-actin loading control.
knockdown. Blot is representative of three independent experiments.At baseline (unstimulated cells), variation in ORMDL3
expression did not induce UPR activation in A549 or
1HAE cells (Additional file 2). 1HAE cells with
ORMDL3 knockdown were also stimulated with tunica-
mycin or thapsigargin (Figure 3C-D). In both condi-
tions, ORMDL3 knockdown did not show increased
UPR activation compared to the negative control. Fur-
thermore, levels of phosphorylated-eIF2α were indis-
tinguishable between ORMDL3 knockdown cells and
controls (Figure 3E).B
D
nockdown. ER stress was induced in 1HAE cells by stimulation with
ls of XBP-1u, XBP-1s, and CHOP were quantified and compared to
ith C) tunicamycin or D) thapsigargin for 4 hours. Relative gene
cramble (a non-specific) siRNA. Data represent the mean ± SEM of
y ANOVA with Bonferroni post-test. *** p < 0.001, ** p < 0.01,
Lysates are from unstimulated 1HAE cells 24 hours after ORMDL3
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multiple genes involved in inflammation, asthma & allergy
To expand our search for immune functions potentially
altered by ORMDL3, the expression of 168 genes was
determined at two time points (2 and 24 hours) follow-
ing stimulation with TNF-α. We performed PCR arrays
to profile expression of cytokines, chemokines, and key
genes involved in asthma and allergy (a complete list of
genes that were studied can be found in Additional file 1).
Gene expression was compared between 1HAE cells
with high (plasmid + 500 nM scramble siRNA) and low
(plasmid + 500 nM of ORMDL3 siRNA) ORMDL3 ex-
pression that were stimulated for 24 hours with TNF-α.
Stimulation with TNF-α induced a robust inflammatory re-
sponse in the cells, enabling us to observe whether vari-
ation in basal ORMDL3 levels impacts the immune
response. These arrays identified eight genes (CCL2, TSLP,
CSF2, CCL5, VEGFA, ADRB2, IL1RL1, and IL13RA1),
shown in Figure 4, that appeared to be differentially regu-
lated by more than 1.5 fold and that were expressed at rela-
tively high levels (average threshold cycle <30). However,
upon replication to validate these results, we determined
that the differences were not statistically significant.
The same arrays were performed on cells stimulated for
2 hours with TNF-α. The same conditions for “high” and
“low” ORMDL3 expression were used. From our results,
we identified only one gene, IL23A, that was differentially
regulated by more than 1.5 fold (fold regulation −2.37)Figure 4 PCR array. Results shown are 168 genes profiled from
two PCR arrays: Allergy & Asthma and Human Cytokines &
Chemokines (Qiagen). 1HAE cells with high or low ORMDL3
expression were stimulated with TNF-α for 24 hours and differences
in gene expression were compared. Comparing low ORMDL3
expression to high ORMDL3 expression, circles are genes with less
than 1.5 fold change and triangles are genes down-regulated by
more than 1.5 fold.and amplified at cycle <30. Replication and comparison of
IL23A expression between knockdown conditions yielded
no significant difference. No other genes, as identified in
the previous arrays, were found to be differentially regu-
lated at this time point. These results suggest that
ORMDL3 variation does not have a meaningful impact on
expression of a large panel of immune-related genes in air-
way epithelial cells.
Discussion
Asthma is a complex disease affecting many individuals
in the developed world. Genome-wide association stud-
ies have recently been used to identify genetic causes for
such complex diseases. One particular gene, ORMDL3,
is of interest because of its association with asthma, IBD,
and Type I diabetes – all of which are caused by
immune-mediated pathology [6,10,22,38,39]. The gene
ORMDL3 is an ER-membrane protein and is potentially
involved in Ca2+-signaling in the ER and sphingolipid
synthesis [20,21,40]. It has also been correlated to activa-
tion of the UPR, though the mechanisms remain unclear
[21]. Activation of the UPR may be biologically relevant,
as ER stress, the UPR, and inflammation have all been
linked [23]. However, the functional role ORMDL3 in
the pathogenesis of asthma has yet to be elucidated.
Airway epithelial cells play an important role in innate
immunity and in the development of asthma. Current
findings in literature indicate that ORMDL3 is involved
in immunity and that asthmatics have higher expression
of the gene than non-asthmatics [18,21,22]. A recent
study by Miller et al. also investigated the role of
ORMDL3 in airway epithelial cells. They reported that
in vitro overexpression of ORMDL3 activated the ATF6
pathway of the UPR and induced expression of several
genes with potential importance in the pathogenesis of
asthma [28]. Our investigation, in contrast, focuses on the
effect of variation of ORMDL3 expression levels, at base-
line, on the innate immune responsiveness of airway epi-
thelial cells. By manipulating ORMDL3 expression in vitro
to mimic differences in gene expression established be-
tween asthmatics and healthy individuals, we aimed to
understand the role of ORMDL3 on the innate immune
response and UPR activation status in airway epithelial
cells. This method ensured control and the confidence
that any effect on the innate immune response was in fact
correlated with a change in ORMDL3 expression levels. If
the same experiments were performed on ex vivo airway
cells of patients, genetic and other differences between
individuals could have affected the results.
After knockdown of ORMDL3 in vitro, cells were stimu-
lated with cytokines (TNF-α, IL-1β) or common microbial
components (LPS, flagellin). We monitored production of
interleukin-6 (IL-6) and interleukin-8 (IL-8) (alias CXCL8),
two pro-inflammatory cytokines produced by airway cells
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is elevated in individuals with asthma [41] and is also regu-
lated by ATF6 during activation of the UPR [42]. Similarly,
transfection of ORMDL3 into human airway epithelial cells
triggers ATF6 activation and IL-8 secretion [28]. However,
in our experimental system, variation in ORMDL3 expres-
sion levels did not affect NF-κB-induced innate immune
production of IL-6 and IL-8 in airway epithelial cells.
We next explored the effects of ORMDL3 expression on
activation of the UPR. UPR signaling cascades are initiated
in response to ER stress, and restoration of homeostasis is
achieved by attenuating translation, restoring protein fold-
ing, or degrading misfolded proteins [24]. Although often
associated with abnormal physiological conditions, the
UPR plays a central beneficial role in normal physiology;
as illustrated by the role of the UPR in terminal B cell dif-
ferentiation which requires a massive increase in the bio-
synthetic capacity to synthesize antibodies in response to
infection [43]. However, the ER stress response and UPR
can also initiate inflammation through induction of cyto-
kine production or activation of transcriptional regulators
of inflammatory genes. Cytokines IL-6 and IL-8 are exam-
ples of genes that may be induced by UPR activation [23].
ER stress and the UPR have been implicated in many
immune-related diseases including IBD, diabetes, chronic
obstructive pulmonary disease (COPD), arthritis, and neu-
rodegenerative inflammatory diseases [44]. It is poorly
understood whether ER stress is an underlying cause of
disease or if its induction is a result of chronic inflamma-
tion. Indeed, it is possible that environment factors such
as infection or inhalation of smoke particles can activate
the UPR, triggering the onset of lung disease in genetically
predisposed individuals [45]. However, it is also possible
that ER stress is exacerbated by inflammation and contri-
butes to the perpetuation of the disease.
Cantero-Recasens et al. previously reported that
ORMDL3 overexpression activated the PERK pathway, but
did not affect the IRE1 pathway of the UPR [21]. In con-
trast, Miller et al. reported that ORMDL3 overexpression
activated the ATF6 pathway, but not the PERK or IRE1
pathways [28]. In our study, we chose four markers of
UPR activation: XBP-1u, XBP-1s, CHOP, and p-eIF2α.
With activation of the UPR, we expect downregulation of
XBP-1u and upregulation of XBP-1s and CHOP. However,
our results demonstrate that knockdown of ORMDL3
does not activate the UPR, in either unstimulated or sti-
mulated cells. Immunoblot analysis also showed no
change in p-eIF2α levels with ORMDL3 knockdown. Fur-
thermore, downstream markers of UPR activation, IL-6
and IL-8 cytokines, were produced at similar levels in un-
stimulated cells with varying ORMDL3 levels. This further
supports our results that ORMDL3 does not activate the
UPR. Differences in our results compared to previous
work might be due to the different types of cells,conditions, or markers used. It is possible that the effects
of variation in ORMDL3 expression are a cell type-
dependent phenomenon. While no effect on the inflam-
matory response was detected in airway cells, other cells
types such as dendritic cells or T cells may be affected by
altered ORMDL3 expression. Observations made by Lluis
et al. suggest that the 17q21 locus may potentially play a
role in T-cell development [18].
Taking a broader approach, PCR arrays looking at ex-
pression of 168 common immunity genes were per-
formed. We reasoned that although ORMDL3 levels may
not affect the production of IL-6 or IL-8 cytokines, per-
haps they were impacting gene expression of other im-
portant immune genes, such as IL-33, IL-25 and TSLP,
which have all been implicated in asthma pathogenesis
[46]. Verification of differential expression of these genes
at a transcript level, however, did not show any significant
changes between the ORMDL3 knockdown conditions.
This suggests that altering ORMDL3 expression does not
have a profound effect on the expression of innate im-
mune genes upon stimulation in the airway epithelia.
However, there may be other genes that are affected that
were not investigated in this study. Pfeifer et al. recently
showed that IL-17C cytokine is expressed by human bron-
chial epithelial cells and is induced by bacterial infection
[47]. It may be worthwhile in future experiments to inves-
tigate a broader range of immune-related genes. Interest-
ingly, we did not observe changes to expression of the
genes reported by Miller et al., MMP-9, CCL-20, CXCL-
10, CXCL-11, or IL-8. This variance may be explained by
differences in experimental conditions. Our study exam-
ined outcomes in gene expression after stimulation of cells
co-transfected with ORMDL3 and ORMDL3-specific
siRNA, while the other study used a different experimental
approach.
Although this study focused exclusively on the poten-
tial role of ORMDL3 in asthma pathogenesis, it is pos-
sible that neighboring genes such as GSDML contribute
to disease susceptibility at this locus. Many groups con-
sider ORMDL3 as an ‘asthma gene’; however, it should
be acknowledged that the identified SNPs associating
this gene to asthma susceptibility are not located in the
gene itself. Even so, these polymorphisms have been
consistently correlated with increased odds of asthma
risk, highlighting the importance of this locus in disease
susceptibility [6-11,13,14].
Our data show that variation in ORMDL3 expression is
not correlated with differential innate immune responses
to stimuli or activation of the UPR in vitro in airway epi-
thelial cells. Taken together, our results are biologically
relevant because they suggest that normal human vari-
ation of ORMDL3 expression is not likely an important
factor in increasing the innate immune response of airway
cells we observe in asthmatics. Despite these results, this
Hsu and Turvey Allergy, Asthma & Clinical Immunology 2013, 9:4 Page 9 of 10
http://www.aacijournal.com/content/9/1/4gene remains an important candidate for asthma suscepti-
bility. More research is required to elucidate its role in
asthma pathogenesis and its potential role as an initial
trigger of inflammation. By increasing our understanding
of the mechanisms responsible for allergic and atopic dis-
ease development, new treatments can then be developed.
Thus, we can reduce inflammatory responses by targeting
the potential triggers, rather than the symptoms, of the
disease. In doing so, we will ultimately reduce the morbid-
ity, mortality, and socio-economic burden of asthma and
related allergic diseases.
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